Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Phase 1

• Conditions: Amphetamine-Related Disorders

• Registration Number: NCT00040040
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Detailed Description

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Study Timeline

• Study Start: 2002-06
• Study First Submitted QC: 2002-06-17
• Study First Submitted: 2002-06-18
• Study First Posted: 2002-06-18
• Status Verified: 2003-08
• Study Completion: 2003-09
• Last Update Submitted: 2017-01-10
• Last Update Posted: 2017-01-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Please contact site director for more details.

Exclusion Criteria

Please contact site director for more details.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychological effects
BP, HR

Trial Locations

Locations (2)

UCLA Integrated Substance Abuse Program; 🇺🇸 Los Angeles, California, United States

University of Texas Health Science Center; 🇺🇸 Houston, Texas, United States